Trials / Recruiting
RecruitingNCT07102082
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
Ifluence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effect
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Roswell Park Cancer Institute · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.
Detailed description
Primary Objectives: To assess the influence of smokeless tobacco products' modified risk claims on: 1. Product demand (measured as willingness to pay in USD) using an experimental auction approach; and 2. Perceived risk of tobacco-associated diseases as assessed using questionnaire-based measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Modified Risk - None | Participants view ads with no modified risk claim |
| BEHAVIORAL | Modified Risk Claim | Participants view ads with a modified risk claim |
Timeline
- Start date
- 2025-09-25
- Primary completion
- 2026-11-30
- Completion
- 2026-11-30
- First posted
- 2025-08-03
- Last updated
- 2025-12-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07102082. Inclusion in this directory is not an endorsement.